Differences were statistically significant between tumoral LLT1 expression and stroma- and tumor-infiltrating CD68+ macrophages (Kruskal–Wallis test, p = 0.03 and p = 0.001, respectively), and also tumor-infiltrating CD163+ macrophages (Kruskal–Wallis test, p = 0.002). The gene discussed is CD163; the disease is neoplasm.